A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels

Clinical trial NCT02010944 · COMPLETED

Trial details

NCT number: NCT02010944
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Phase 1 Bioavailability Healthy Subjects

Start date: 2012-09-01
Primary completion: 2012-11-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.